Similar articles for PMID: 16282842

Year	Number of Results
1990	1
1993	2
1994	1
1995	3
1996	2
1997	2
1998	5
1999	7
2000	3
2001	9
2002	6
2003	7
2004	4
2005	8
2006	4
2007	3
2008	4
2009	3
2010	6
2011	4
2012	2
2013	1
2015	4
2016	4
2017	1
2019	1
2020	3
2021	1
2022	1

1

Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study.

Muehlbacher M, Nickel MK, Nickel C, Kettler C, Lahmann C, Pedrosa Gil F, Leiberich PK, Rother N, Bachler E, Fartacek R, Kaplan P, Tritt K, Mitterlehner F, Anvar J, Rother WK, Loew TH, Egger C. Muehlbacher M, et al. J Clin Psychopharmacol. 2005 Dec;25(6):580-3. doi: 10.1097/01.jcp.0000186871.04984.8d. J Clin Psychopharmacol. 2005. PMID: 16282842 Clinical Trial.

2

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.

Schutters SI, Van Megen HJ, Van Veen JF, Denys DA, Westenberg HG. Schutters SI, et al. Int Clin Psychopharmacol. 2010 Sep;25(5):302-4. doi: 10.1097/yic.0b013e32833a4d71. Int Clin Psychopharmacol. 2010. PMID: 20715300 Clinical Trial.

3

Mirtazapine in social anxiety disorder: a pilot study.

Van Veen JF, Van Vliet IM, Westenberg HG. Van Veen JF, et al. Int Clin Psychopharmacol. 2002 Nov;17(6):315-7. doi: 10.1097/00004850-200211000-00008. Int Clin Psychopharmacol. 2002. PMID: 12409686 Clinical Trial.

4

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group. Versiani M, et al. CNS Drugs. 2005;19(2):137-46. doi: 10.2165/00023210-200519020-00004. CNS Drugs. 2005. PMID: 15697327 Clinical Trial.

5

A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.

Fawcett J, Barkin RL. Fawcett J, et al. J Clin Psychiatry. 1998 Mar;59(3):123-7. J Clin Psychiatry. 1998. PMID: 9541155

6

Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.

Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A. Poyurovsky M, et al. Biol Psychiatry. 2006 Jun 1;59(11):1071-7. doi: 10.1016/j.biopsych.2005.12.007. Epub 2006 Feb 21. Biol Psychiatry. 2006. PMID: 16497273 Clinical Trial.

7

Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.

Mrakotsky C, Masek B, Biederman J, Raches D, Hsin O, Forbes P, de Moor C, DeMaso DR, Gonzalez-Heydrich J. Mrakotsky C, et al. J Anxiety Disord. 2008;22(1):88-97. doi: 10.1016/j.janxdis.2007.01.005. Epub 2007 Feb 3. J Anxiety Disord. 2008. PMID: 17419001 Clinical Trial.

8

Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN. Koran LM, et al. J Clin Psychiatry. 2005 Apr;66(4):515-20. J Clin Psychiatry. 2005. PMID: 15816795 Clinical Trial.

9

Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan.

Miki K, Murakami M, Oka H, Onozawa K, Yoshida S, Osada K. Miki K, et al. Pain. 2016 Sep;157(9):2089-2096. doi: 10.1097/j.pain.0000000000000622. Pain. 2016. PMID: 27218868 Free PMC article. Clinical Trial.

10

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

Hong CJ, Hu WH, Chen CC, Hsiao CC, Tsai SJ, Ruwe FJ. Hong CJ, et al. J Clin Psychiatry. 2003 Aug;64(8):921-6. doi: 10.4088/jcp.v64n0810. J Clin Psychiatry. 2003. PMID: 12927007 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed